FDC
|
The Current P/B Ratio of FDC is 2.23.
| Share Price | ₹340.0 | Sep 02,2026 |
| Market Cap | ₹5,534.4 Cr | |
| Book Value | ₹2,485.1 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.23x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of FDC
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹5,534.4 Cr] as on Sep 02,2026
(/) Book Value [ ₹2,485.1 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.23x ]
Thus, for FDC , the investors are currently willing to pay '2.23 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of FDC !
The chart below summarizes the trend in P/B Ratio of FDC over the last five years.
Historical PB (Price/Book ) ratio chart of FDC
PB Ratio Performance Analysis for FDC
- FDC 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.65x.
- FDC 's operated at median p/b ratio of 2.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/b ratio peaked in Mar2024 at 3.3x.
- FDC 's p/b ratio hit its five-year low in Mar2023 of 2.15x.
How does FDC 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| FDC | 2,485.11 | 2.23 | 5,534.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.55 | 463,791.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 14.62 | 245,081.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.69 | 190,351.0 |
| CIPLA LTD | 34,369.40 | 3.32 | 114,163.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.57 | 96,906.3 |
| MANKIND PHARMA LTD | 16,252.60 | 6.05 | 98,304.7 |
| LUPIN LTD | 22,384.10 | 4.40 | 98,431.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.24 | 114,833.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.52 | 95,299.8 |
| LAURUS LABS LTD | 5,275.08 | 19.08 | 100,660.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs FDC 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.23x |
| Max industry PB | 22.69x |
| Median industry PB | 4.40x |
| Average industry PB | 7.93x |
You may also like the below Video Courses